For musculoskeletal indications, most patients at our Doral clinic report a noticeable reduction in pain within 2 to 3 weeks and a functional improvement (range of motion, strength, load tolerance) by weeks 4 to 8
Each capsule contains a standardized research formulation consisting of 500mcg of BPC-157 and 500mcg of TB-500, for a total of 1000mcg per capsule
PMC 297469
Peptide therapy may be appropriate for individuals experiencing fatigue, weight gain, slow recovery, hormonal imbalance, sleep disruption, joint or muscle discomfort, or age-related changes in skin, metabolism, or cognition
BPC-157 might offer more noticeable benefits in this population precisely because they have more room for improvement
On the plus side, the product is uncaffeinated and it does include a wide range of well-dosed vitamins and minerals